Hupan Pharmaceutical

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about
Hupan Pharmaceutical, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Hupan Pharmaceutical please access Flcube.com

TYK Medicines' Asandeutertinib (TY‑9591) Set to Ship First Commercial Batch – Qilu Pharmaceutical to Launch China Sales of the NMPA‑Approved EGFR‑TKI
CompanyDrug

TYK Medicines’ Asandeutertinib (TY‑9591) Set to Ship First Commercial Batch – Qilu Pharmaceutical to Launch China Sales of the NMPA‑Approved EGFR‑TKI

TYK Medicines (HKG: 2410) announced that its independently developed new drug, asandeutertinib (TY‑9591), is set to complete production, with the first batch expected to be officially shipped via commercial channels…

Abbisko's PIMJETMI (Pimicotinib) Wins FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor – First U.S. Green Light for the China‑Born CSF‑1R Inhibitor

Abbisko’s PIMJETMI (Pimicotinib) Wins FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor – First U.S. Green Light for the China‑Born CSF‑1R Inhibitor

Insurance Association of China Unveils First Commercial Insurance Recommended Drug List – 58 Drugs and Devices, Nearly 60% Outside the NRDL

Insurance Association of China Unveils First Commercial Insurance Recommended Drug List – 58 Drugs and Devices, Nearly 60% Outside the NRDL

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Lakeside Holding's Hupan Pharmaceutical Partners with Sinopharm Group Hubei for Supply Chain Services
CompanyDeals

Lakeside Holding’s Hupan Pharmaceutical Partners with Sinopharm Group Hubei for Supply Chain Services